Chitotriosidase activity in plasma and mononuclear and polymorphonuclear

被引:32
|
作者
Bouzas, L [1 ]
Guinarte, JC [1 ]
Tutor, JC [1 ]
机构
[1] Hosp Clin Univ, Cent Lab, Santiago De Compostela, Spain
关键词
chitotriosidase; mononuclear leukocytes; polymorphonuclear leukocytes; plasma; chitotriosidase deficiency;
D O I
10.1002/jcla.10108
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In the general population, about 5% of individuals are homozygotic and 35% are heterozygotic carriers for chitotriosiclase (ChT) deficiency. Activated macrophages are considered to be the main source of plasma ChT activity, which permits the biochemical characterization of homozygote deficients. However, in the case of detecting heterozygotic carriers, the results are often inconclusive. The activities of ChT in plasma and mononuclear (MN) and polymorphonuclear (PMN) leukocytes were determined in 169 control subjects (72 males and 97 females) with a mean age (+/- SD) of 47.5+/-9.7 years (range 18-96 years). The specific enzyme activity was in PMN leukocytes >MN leukocytes >plasma, with a highly significant partial correlation being found between the activities of ChT in plasma and PM leukocytes (r=0.578, P<0.001). A significant correlation was found between the age of the patients studied and plasma ChT activity (r = 0.568, P < 0.001). No significant correlation was found for enzyme activities in M (r=0.105) or in PM leukocytes (r=0.043). The results obtained suggest that, in normal physiological conditions, PMN leukocytes may secrete ChT to the plasma. Although the activities of ChT in M and PMN leukocytes are not affected by demographic factors, it is not possible to use them for the biochemical detection of ChT-deficient heterozygotic carriers. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:271 / 275
页数:5
相关论文
共 50 条
  • [1] Plasma chitotriosidase activity and malaria
    Chien, YH
    Chen, JH
    Hwu, WL
    CLINICA CHIMICA ACTA, 2005, 353 (1-2) : 215 - 215
  • [2] Plasma chitotriosidase activity in patients with β-thalassemia
    Barone, R
    Di Gregorio, F
    Romeo, MA
    Schilirò, G
    Pavone, L
    BLOOD CELLS MOLECULES AND DISEASES, 1999, 25 (01) : 1 - 8
  • [3] Plasma chitotriosidase activity in patients with β-thalassemia
    Barone, R
    Malaguarnera, L
    Angius, A
    Musumeci, S
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 72 (04) : 285 - 286
  • [4] Plasma chitotriosidase activity in patients with β-thalassemia
    Altarescu, G
    Rudensky, B
    Abrahamov, A
    Goldfarb, A
    Rund, D
    Zimran, A
    Elstein, D
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (01) : 7 - 10
  • [5] Chitotriosidase Activity in Plasma and COPD Exacerbations
    Matevz Harlander
    David Lestan
    Matjaz Turel
    Lung, 2020, 198 : 299 - 306
  • [6] Chitotriosidase Activity in Plasma and COPD Exacerbations
    Harlander, Matevz
    Lestan, David
    Turel, Matjaz
    LUNG, 2020, 198 (02) : 299 - 306
  • [7] Plasma chitotriosidase activity and malaria - Response
    Musumeci, S
    CLINICA CHIMICA ACTA, 2005, 353 (1-2) : 217 - 217
  • [8] Plasma chitotriosidase activity in multiple sclerosis
    Comabella, M.
    Dominguez, C.
    Rio, J.
    Martin-Gallan, P.
    Vilches, A.
    Vilarrasa, N.
    Espejo, C.
    Montalban, X.
    CLINICAL IMMUNOLOGY, 2009, 131 (02) : 216 - 222
  • [9] Chitotriosidase plasma activity in nephropathic cystinosis
    Xaidara, A.
    Karavitakis, E. M.
    Kosma, K.
    Emma, F.
    Dimitriou, E.
    Michelakakis, H.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2009, 32 (01) : S157 - S159
  • [10] Plasma chitotriosidase activity in patients with multiple sclerosis
    Comabella, Manuel
    Dominguez, C.
    Rio, Jordi
    Martin-Gallan, P.
    Vilches, A.
    Espejo, Carmen
    Montalban, Xavier
    MULTIPLE SCLEROSIS, 2008, 14 : S228 - S229